TABLE 2.

Peptides sequences in each peptide pool analyzed by ELISPOT IFN- γ assay

Peptide pool	Dengue virus region	Peptide sequence	Virus specificity	HLA type	Score
A	AnchC	ALVAFLRFL49-57	DV2	A*02/24	27
	AnchC	GRMLNILNR89-97	DV2	B*27	30
	CP	RVSTVQQLTK22-31	DV2	A*03/11	30
	CP	ILKRWGTIK65-73	DV2	A*03/11	32
	PrM	QEKGKSLL17-24	DV2	A*02/24	30
B	E	MAKNKPTL34-41	DV1, DV2, DV3	B*08	34
	E	FLDLPLPWL213-221	DV2	A*02/24	27
	E	SLSVSLVLV474-482	DV2	A*02/24	28
	E	SLVLVGVVTL478-487	DV2	A*02/24	30
	NS1	SLRTTTASGK297-305	DV2, DV4	A*03/11	32
C	NS1	ILSENEVKL78-86	DV2	A*02/24	28
	NS1	PLKEKEENL337-345	DV2	B*08	38
	NS2A	MLRTRVGTK22-30	DV2	A*03/11	30
	NS2A	ALALGMMVLK126-135	DV2	A*03/11	29
	NS2A	AVILQNAWK158-166	DV2	A*03/11	30
D	NS2B	ELERAADVK52-60	DV2	A*03/11	31
	NS2B	ILIRTGLLVI97-106	DV2	A*02/24	27
	NS3	RIKQKGIL25-32	DV2	B*08	34
	NS3	RIEPSWADVK64-74	DV2	A*03/11	30
	NS3	AIKRGLRTL112-120	DV2	A*02/24	27
	NS3	RVIDPRRCMK422-431	DV2	A*03/11	34
E	NS3	DKKGKVVGL142-150	DV2	B*08	32
	NS4A	ALSELPETL44-52	DV2	A*02/24	27
	NS4A	LLLLTLLATV55-64	DV2	A*02/24	31
	NS4A	LLLTLLATV56-64	DV2	A*02/24	33
	NS4B	LEKTKKDL6-13	DV2	B*08	30
	NS4B	AIIGPGLQAK119-128	DV1, DV2, DV3, DV4	A*03/11	27
F	NS5	NVREVKGLTK96-105	DV2	A*03/11	31
	NS5	VLNPYMPSV182-190	DV1, 2	A*02/24	28
	NS5	KITAEWLWK375-383	DV2, 3	A*03/11	27
	NS5	KLAEAIFKL563-571	DV2	A*02/24	31
	NS5	AISGDDCVVK659-668	DV2	A*03/11	30